← back to search

Selim Corbacioglu

University of Regensburg · DE
Area of research
Hematology · Genetics
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Hemoglobinopathies and Related Disorders, and Acute Lymphoblastic Leukemia research.
h-index
50
citations
12,849
works
291
NIH funding
primary concept
Medicine
email

Recent publications

Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor
Genome Medicine 2025cited by 12position: middledoi
Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort
Blood Advances 2025cited by 11position: middledoi
Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group
Blood Advances 2025cited by 5position: middledoi
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group
Bone Marrow Transplantation 2025cited by 5position: middledoi
Improvements in health-related quality of life in patients with transfusion-dependent β-thalassemia after exagamglogene autotemcel
Blood Advances 2025cited by 3position: middledoi
αß T-cell depleted haploidentical stem cell transplantation for pediatric and young adult patients with transfusion-dependent thalassemia
Bone Marrow Transplantation 2025cited by 3position: lastdoi
First results of exagamglogene autotemcel in pediatric patients aged 5-11 years with transfusion-dependent β-thalassemia or sickle cell disease with recurrent severe vaso-occlusive crises
Blood 2025cited by 2position: middledoi
Long-term follow-up demonstrates durable clinical benefits of exagamglogene autotemcel for sickle cell disease with recurrent vaso-occlusive crises: Final results of climb SCD-121
Blood 2025cited by 1position: middledoi
Durable Clinical Benefits in Transfusion-Dependent Β-Thalassemia with Exagamglogene Autotemcel
Transplantation and Cellular Therapy 2025cited by 1position: middledoi
Single unrelated umbilical cord blood versus unmanipulated haploidentical HCT using PTCy in pediatric AML: a retrospective study on behalf of the EBMT PDWP and CTIWP
Bone Marrow Transplantation 2025cited by 1position: middledoi
Late effects after hematopoietic stem cell transplantation in patients with HLH: A Histiocyte Society, PDWP, IEWP, and TCWP EBMT Study
Journal of Allergy and Clinical Immunology 2025cited by 1position: lastdoi
Durable Clinical Benefits in Severe Sickle Cell Disease with Exagamglogene Autotemcel
Transplantation and Cellular Therapy 2025cited by 0position: middledoi
Raising Awareness: Real World Data On Palliative Care for Advanced Pediatric Cancers in Bavaria
Pediatric Blood & Cancer 2025cited by 0position: middledoi
The Impact of Pre-Transplant Extramedullary Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Children- on Behalf of PDWP/EBMT
Research Square 2025cited by 0position: lastdoi
Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP
Bone Marrow Transplantation 2025cited by 0position: middledoi
<i>Erratum</i> to<i>: “</i>Donor cytomegalovirus serology impacts overall survival in children receiving first unrelated hematopoietic stem cell transplant for acute leukemia: European Society of Bone Marrow Transplantation Pediatric Diseases Working Party Study”
Haematologica 2025cited by 0position: middledoi
682P CSF liquid biopsy as an innovative tool for research on patients with leptomeningeal metastasis and pediatric brain tumors
Annals of Oncology 2025cited by 0position: middledoi
Interplay between acute graft-versus-host disease and graft-versus-leukemia effect in pediatric acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: implications for relapse incidence and survival – an EBMT PDWP retrospective study
Bone Marrow Transplantation 2025cited by 0position: middledoi
Impaired T Cell Immunity in Children and Adolescents with Hodgkin Lymphoma (HL)
Klinische Pädiatrie 2025cited by 0position: middledoi
The need for a subsequent HCT is a late & continuous risk and with significant impact in overall survival in haemoaglobinopathies: Real-world data from 2000–2022. an analysis of the european society for blood and marrow transplantation (EBMT) hemoglobinopathy working party.
Blood 2025cited by 0position: middledoi
Comparison of outcomes in pediatric patients with acute leukemia undergoing allogeneic HLA-haploidentical hematopoietic stem cell transplantation (HSCT) after in vitro a/b T- and CD19-cell depletion or In Vivo administration of post-transplant cyclophosphamide: An EBMT pediatric working party study
Blood 2025cited by 0position: middledoi
Exagamglogene Autotemcel for Severe Sickle Cell Disease
New England Journal of Medicine 2024cited by 361position: middledoi
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia
New England Journal of Medicine 2024cited by 178position: middledoi
Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT)
Cytotherapy 2024cited by 26position: middledoi
Outcomes of hematopoietic stem cell transplantation in 813 pediatric patients with Fanconi anemia
Blood 2024cited by 24position: middledoi
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial
The Lancet Oncology 2024cited by 20position: firstdoi
Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study
Haematologica 2024cited by 15position: lastdoi
Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile
Neuro-Oncology 2024cited by 11position: middledoi
LoDEI: a robust and sensitive tool to detect transcriptome-wide differential A-to-I editing in RNA-seq data
Nature Communications 2024cited by 9position: middledoi
Cytogenetic abnormalities predict survival after allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a PDWP/EBMT study
Bone Marrow Transplantation 2024cited by 8position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Franco Locatelli · Assistance Publique – Hôpitaux de Paris21 papers (2015–2025)Paul G. Richardson · Harvard University18 papers (2012–2023)Josu de la Fuente · Imperial College Healthcare NHS Trust15 papers (2020–2025)Peter Bader · Children's Clinical University Hospital15 papers (2013–2024)Mohamad Mohty · Inserm14 papers (2014–2024)Régis Peffault de Latour · Heinrich Heine University Düsseldorf13 papers (2015–2024)Arjan C. Lankester · Leiden University12 papers (2015–2024)Antonio Pagliuca · King's College - North Carolina11 papers (2014–2024)Jean‐Hugues Dalle · Centre National de la Recherche Scientifique11 papers (2020–2024)Christina Peters · Nottingham City Hospital11 papers (2013–2023)Haydar Frangoul · University College London11 papers (2020–2025)John A. Snowden · Sheffield Teaching Hospitals NHS Foundation Trust10 papers (2019–2024) · 10 papers (2017–2025)Ibrahim Yakoub‐Agha · Inserm10 papers (2019–2024)Stephan A. Grupp · University College London10 papers (2012–2025) · 9 papers (2022–2025)Petr Sedláček · Charles University9 papers (2013–2021) · 9 papers (2020–2024)Rafael F. Duarte · Hospital Universitario Puerta de Hierro Majadahonda9 papers (2019–2024)Jan Styczyński · Nicolaus Copernicus University8 papers (2018–2024)